What does Drs Pipeleers & Marichal do?

Drs Pipeleers & Marichal is a research organisation in Roosdaal. Private Limited, started on 1 December 2011, 1 establishment.

What is the address of Drs Pipeleers & Marichal?

The registered office of Drs Pipeleers & Marichal is located at Benedenstraat 5, 1761 Roosdaal.

Is Drs Pipeleers & Marichal still active?

Yes. According to the CBE (29 October 2026) Drs Pipeleers & Marichal is active, legal situation “Normale toestand”, started on 1 December 2011.

Is Drs Pipeleers & Marichal registered on Peppol?

Yes, Drs Pipeleers & Marichal is registered on the Peppol network with ID 0208:0841472129.

What is the enterprise number of Drs Pipeleers & Marichal?

The enterprise number of Drs Pipeleers & Marichal is BE0841472129.

When was Drs Pipeleers & Marichal founded?

Drs Pipeleers & Marichal was founded on 1 December 2011.

Who are the directors of Drs Pipeleers & Marichal?

According to the 2025 annual accounts, the directors of Drs Pipeleers & Marichal are: Daniel Pipeleers, Miriam Marichal.

Is Drs Pipeleers & Marichal a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2011; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Drs Pipeleers & Marichal make in 2025?

Drs Pipeleers & Marichal posted a profit after taxes of € 124,215 in financial year 2025.

What is the revenue of Drs Pipeleers & Marichal?

As a small company, Drs Pipeleers & Marichal is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 169,791.

Drs Pipeleers & Marichal (Private Limited) - Roosdaal

Dossier Drs Pipeleers & Marichal, printed on 29 October 2026 from databakkes.be/en/0841472129/drs-pipeleers-marichal. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Drs Pipeleers & Marichal from Roosdaal, company number BE0841472129, closed financial year 2025 with a result of € 124,215 after tax. For that financial year Drs Pipeleers & Marichal recorded a gross margin of € 169,791 and equity of € 2 million. Compared with financial year 2024, the result moved from € 254,562 to € 124,215. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 9, 2026.

What it is worth Growing

€ 2 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 124,215

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 284,573

▼ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2 million.

People and assets in 2025

Vehicles and equipment

€ 8,420

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,150

▲ € 948 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,495

▼ 84% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 214,639 Gross margin 2022: € 214,639 First fiscal year in the series	€ 205,782 Gross margin 2023: € 205,782 ▼ 4% vs 2022 (€ 214,639) Unfavourable step	€ 208,588 Gross margin 2024: € 208,588 ▲ 1% vs 2023 (€ 205,782) Favourable step	€ 169,791 Gross margin 2025: € 169,791 ▼ 19% vs 2024 (€ 208,588) Unfavourable step	▼ 19%
Profit after taxes	€ 122,594 Profit after taxes 2022: € 122,594 First fiscal year in the series	€ 177,500 Profit after taxes 2023: € 177,500 ▲ 45% vs 2022 (€ 122,594) Favourable step	€ 254,562 Profit after taxes 2024: € 254,562 ▲ 43% vs 2023 (€ 177,500) Favourable step	€ 124,215 Profit after taxes 2025: € 124,215 ▼ 51% vs 2024 (€ 254,562) Unfavourable step	▼ 51%
Equity	€ 1,469,694 Equity 2022: € 1,469,694 First fiscal year in the series	€ 1,627,194 Equity 2023: € 1,627,194 ▲ 11% vs 2022 (€ 1,469,694) Favourable step	€ 1,881,756 Equity 2024: € 1,881,756 ▲ 16% vs 2023 (€ 1,627,194) Favourable step	€ 2,005,971 Equity 2025: € 2,005,971 ▲ 7% vs 2024 (€ 1,881,756) Favourable step	▲ 7%
Total debts	€ 32,920 Total debts 2022: € 32,920 First fiscal year in the series	€ 40,179 Total debts 2023: € 40,179 ▲ 22% vs 2022 (€ 32,920) Unfavourable step	€ 45,936 Total debts 2024: € 45,936 ▲ 14% vs 2023 (€ 40,179) Unfavourable step	€ 40,997 Total debts 2025: € 40,997 ▼ 11% vs 2024 (€ 45,936) Favourable step	▼ 11%
Cash	€ 434,481 Cash 2022: € 434,481 First fiscal year in the series	€ 551,883 Cash 2023: € 551,883 ▲ 27% vs 2022 (€ 434,481) Favourable step	€ 398,627 Cash 2024: € 398,627 ▼ 28% vs 2023 (€ 551,883) Unfavourable step	€ 284,573 Cash 2025: € 284,573 ▼ 29% vs 2024 (€ 398,627) Unfavourable step	▼ 29%
Retained profit	€ 1,457,294 Retained profit 2022: € 1,457,294 First fiscal year in the series	€ 1,614,794 Retained profit 2023: € 1,614,794 ▲ 11% vs 2022 (€ 1,457,294) Favourable step	€ 1,869,356 Retained profit 2024: € 1,869,356 ▲ 16% vs 2023 (€ 1,614,794) Favourable step	€ 1,993,571 Retained profit 2025: € 1,993,571 ▲ 7% vs 2024 (€ 1,869,356) Favourable step	▲ 7%
Dividend	€ 16,000 Dividend 2022: € 16,000 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 ▲ 25% vs 2022 (€ 16,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 20,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,502,614 Balance sheet total 2022: € 1,502,614 First fiscal year in the series	€ 1,667,373 Balance sheet total 2023: € 1,667,373 ▲ 11% vs 2022 (€ 1,502,614) Unchanged	€ 1,927,692 Balance sheet total 2024: € 1,927,692 ▲ 16% vs 2023 (€ 1,667,373) Unchanged	€ 2,046,967 Balance sheet total 2025: € 2,046,967 ▲ 6% vs 2024 (€ 1,927,692) Unchanged	▲ 6%

Key figures of Drs Pipeleers & Marichal, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Drs Pipeleers & Marichal?

What happened at Drs Pipeleers & Marichal in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 9, 2026 New annual accounts for financial year 2025: profit of € 124,215 (▼ 51% vs 2024). filed late Source: NBB ↗
Dec 1, 2011 New establishment in Roosdaal. KBO
Dec 1, 2011 Start of the company according to the CBE. KBO
2011 Daniel Pipeleers became a director. NBB
2011 Miriam Marichal became a director. NBB

In short

From € 122,594 profit in 2022 to € 124,215 profit in 2025.

Paid € 276,232 in corporate taxes since 2022.

Best year ever: 2024, with € 254,562 profit.

Paid out € 36,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Daniel Pipeleers Miriam Marichal

OPUS

BETA - CELL

Center for Beta Cell Therapy in Diabetes

Drs Pipeleers & Marichal

Behind Drs Pipeleers & Marichal are Daniel Pipeleers and Miriam Marichal. Daniel Pipeleers is also behind OPUS, BETA - CELL and Center for Beta Cell Therapy in Diabetes.

Directors

According to the 2025 annual accounts

Daniel Pipeleers

Director

Also active at: OPUS, BETA - CELL, Center for Beta Cell Therapy in Diabetes

since 2011

Miriam Marichal

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Benedenstraat 5

1761 Roosdaal

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0841.472.129

VAT number

BE 0841.472.129

Registered office

Benedenstraat 5, 1761 Roosdaal

Names & denominations

Drs Pipeleers & Marichal

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 December 2011

Peppol

Active · Active since 14 Nov 2025

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige gespecialiseerde wetenschappelijke en technische activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

Drs Pipeleers & Marichal

Financials

What happened to Drs Pipeleers & Marichal?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions